MENU
RIGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rigel Pharmaceuticals (RIGL) Ownership - Who owns Rigel Pharmaceuticals?
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
315.73M
P/E Ratio
17.85
Total Cash
77.32M
Projected Growth
N/A
Total Debt
59.97M
Revenue
179.28M
Risk (Beta)
1.31
Dividend Yield
N/A
Total Cash/Share
4.33
Total Debt/Equity
N/A
Revenue/Share
10.14 USD as % of share price
Fundamentals
RIGL
Capitalization
316M
P/E Ratio
17.85
Risk (Beta)
1.31
Dividend Yield
N/A
Total Cash
77.3M
Total Cash/Share
4.33
Total Debt
60M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
10.14%
Revenue
179M
ROE
N/A
Book Value
3.29M
P/B Ratio
96.15
Cash Flow
N/A
Earnings
0.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
18K
Current Ratio
2.13
Current Revenue Per Employee
351195.12
Dividends Per Share - Security
N/A
EBITDA
28.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
89.95
Revenue To Assets
12.44
Shares Held By Institutions
288M
Shares Outstanding - Current
17.9M
Total Liabilities
161M
Total Volume MTD
N/A
Value
-1
Gain YTD
4.964
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage drug development company that discovers and develops novel, small-molecule drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com